FDA approves UCB's drug to treat epilepsy-related seizures

February 19, 2016 2:50 PM

5 0

The U.S. Food and Drug Administration (FDA) approved Belgian drugmaker UCB SA's drug as an add-on therapy to treat partial seizures caused by epilepsy.

The FDA approval comes nearly two months after the European health regulators recommended approval of the drug, Briviact, in Europe.

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page